2023
Cognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: The CBT-ENDURE randomized clinical trial study protocol
Kitay B, Murphy E, Macaluso M, Corlett P, Hershenberg R, Joormann J, Martinez-Kaigi V, Nikayin S, Rhee T, Sanacora G, Shelton R, Thase M, Wilkinson S. Cognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: The CBT-ENDURE randomized clinical trial study protocol. Psychiatry Research 2023, 330: 115585. PMID: 37935086, DOI: 10.1016/j.psychres.2023.115585.Peer-Reviewed Original ResearchConceptsCognitive behavioral therapyMajor depressionSuicidal ideationRelapse preventionBehavioral therapyStudy protocolHigh riskClinical trial study protocolLong-term treatment approachKey secondary outcomesTrial study protocolHigh relapse rateHigh-risk populationSignificant suicidal ideationHospital dischargeSecondary outcomesPrimary outcomeRelapse rateFeasibility trialEsketamineTreatment approachesPatientsSuicide attemptsTherapySupplemental indicationsThe effect of attention bias modification on depressive symptoms in a comorbid sample: a randomized controlled trial
Bø R, Kraft B, Pedersen M, Joormann J, Jonassen R, Osnes K, Harmer C, Landrø N. The effect of attention bias modification on depressive symptoms in a comorbid sample: a randomized controlled trial. Psychological Medicine 2023, 53: 6389-6396. PMID: 36617964, PMCID: PMC10520597, DOI: 10.1017/s0033291722003956.Peer-Reviewed Original ResearchConceptsBeck Depression Inventory-IIDepressive symptomsDouble-blind randomized sham-controlled trialSham conditionRandomized sham-controlled trialSham-controlled trialLong-term outcomesMajor depressive episodeMajor depressive disorderSecondary outcomesPrimary outcomeDepressive episodeDepressive disorderLong-term effectsComorbid disordersComorbid anxietyComorbid sampleConsecutive daysInventory-IIPredictor analysisInventory scoresTotal scoreSymptomsEffects of ABMClinical samples
2022
Derivation and Validation of a Brief Emergency Department-Based Prediction Tool for Posttraumatic Stress After Motor Vehicle Collision
Jones C, An X, Ji Y, Liu M, Zeng D, House S, Beaudoin F, Stevens J, Neylan T, Clifford G, Jovanovic T, Linnstaedt S, Germine L, Bollen K, Rauch S, Haran J, Storrow A, Lewandowski C, Musey P, Hendry P, Sheikh S, Punches B, Lyons M, Kurz M, Swor R, McGrath M, Hudak L, Pascual J, Seamon M, Datner E, Harris E, Chang A, Pearson C, Peak D, Merchant R, Domeier R, Rathlev N, O'Neil B, Sergot P, Sanchez L, Bruce S, Miller M, Pietrzak R, Joormann J, Barch D, Pizzagalli D, Sheridan J, Smoller J, Harte S, Elliott J, Koenen K, Ressler K, Kessler R, McLean S. Derivation and Validation of a Brief Emergency Department-Based Prediction Tool for Posttraumatic Stress After Motor Vehicle Collision. Annals Of Emergency Medicine 2022, 81: 249-261. PMID: 36328855, PMCID: PMC11181458, DOI: 10.1016/j.annemergmed.2022.08.011.Peer-Reviewed Original ResearchConceptsMotor vehicle collisionsPosttraumatic stress symptomsValidation cohortSubstantial posttraumatic stress symptomsStress symptomsVehicle collisionsRisk-stratify individualsClinical decision support toolEmergency department patientsPersistent posttraumatic stress symptomsPreventive intervention trialNumber of EDsEase of administrationDerivation cohortPrimary outcomeDepartment patientsIntervention trialsBaseline healthHigh riskSymptomsCohortExternal validationPsychological recoveryDiscriminative abilityPosttraumatic stress